These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32850303)

  • 1. Genetic Alterations and Transcriptional Expression of m
    Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
    Front Oncol; 2020; 10():900. PubMed ID: 32850303
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiles of m
    Li W; Chen QF; Huang T; Shen L; Huang ZL; Wu P
    Oncol Lett; 2020 Apr; 19(4):3296-3306. PubMed ID: 32256825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m
    Xu Y; He X; Deng J; Xiong L; Li Y; Zhang X; Chen W; Liu X; Xu X
    Front Cell Dev Biol; 2021; 9():681745. PubMed ID: 34277622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Su Y; Huang J; Hu J
    Front Oncol; 2019; 9():1038. PubMed ID: 31681576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
    Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
    Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X; Lv YF; He J; Cao Y; Li CQ; Guo QN
    J Hepatocell Carcinoma; 2021; 8():85-101. PubMed ID: 33738268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma.
    Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J
    Front Oncol; 2020; 10():1435. PubMed ID: 32974160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
    Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
    [No Abstract]   [Full Text] [Related]  

  • 9. An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
    Du Y; Ma Y; Zhu Q; Liu T; Jiao Y; Yuan P; Wang X
    Front Pharmacol; 2021; 12():707930. PubMed ID: 34248650
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma.
    Zhu P; Ren Q; He N; Zhou C; Jin Q; Gong Z
    Oncol Lett; 2021 Mar; 21(3):221. PubMed ID: 33613710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
    Wang P; Wang X; Zheng L; Zhuang C
    Front Genet; 2020; 11():540186. PubMed ID: 33133142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma.
    Liu W; Zhong C; Lv D; Tang M; Xie F
    Front Genet; 2020; 11():863. PubMed ID: 32903675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 15. The pattern of expression and prognostic value of key regulators for m
    Chen J; Yao S; Sun Z; Wang Y; Yue J; Cui Y; Yu C; Xu H; Li L
    Front Genet; 2022; 13():894325. PubMed ID: 36118897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma.
    Jin C; Li R; Deng T; Li J; Yang Y; Li H; Chen K; Xiong H; Chen G; Wang Y
    Front Mol Biosci; 2021; 8():784553. PubMed ID: 34988119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Chai RC; Wu F; Wang QX; Zhang S; Zhang KN; Liu YQ; Zhao Z; Jiang T; Wang YZ; Kang CS
    Aging (Albany NY); 2019 Feb; 11(4):1204-1225. PubMed ID: 30810537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N
    Li G; Zhang Y; Du X; Li W; Zhang Y; Han T; Zheng Z
    Transl Cancer Res; 2020 Jan; 9(1):323-334. PubMed ID: 35117186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma.
    Xu N; Chen J; He G; Gao L; Zhang D
    J Cancer; 2020; 11(17):5187-5197. PubMed ID: 32742465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.